Darren Walsh

Darren first joined Orchard Therapeutics as Senior Director – Market Access & Govt. Affairs in 2019 where he was responsible for securing patient access and reimbursement for Orchard’s portfolio of transformative gene therapies and building out the function as required for commercialisation. Currently, Darren is the General Manager UK/ROI for Orchard Therapeutics where he is responsible for securing rapid and unrestricted access across the UK for gene therapy Libmeldy™ and building out of affiliates to continue commercial success. He is also working to secure NBS for current pipeline products.